Unibail-Rodamco-Westfield SE : Investors could aim for a turn-around of the trend
Entry price | Target | Stop-loss | Potential |
---|
€223.4 |
€230 |
€219.49 |
+2.95% |
---|
The technical chart pattern of Unibail-Rodamco shares shows signs of a medium term reversal, which speaks in favor of opening new long positions.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● Historically, the company has been releasing figures that are above expectations.
● Its low valuation, with P/E ratio at 9.94 and 10.74 for the ongoing fiscal year and 2017 respectively, makes the stock pretty attractive with regard to earnings multiples.
● The company is one of the best yield companies with high dividend expectations.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses● One of the major weak points of the company is its financial situation.
● The company's "enterprise value to sales" ratio is among the highest in the world.
● The technical configuration over the long term remains negative on the weekly chart below the resistance level at 227.15 EUR
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.